[1] [1] Mascolo A, di Mauro G, Cappetta D, et al. Current and future therapeutic perspective in chronic heart failure[J]. Pharmacol Res, 2022, 175: 106035.

[2] [2] Hinton A Jr, Claypool SM, Neikirk K, et al. Mitochondrial structure and function in human heart failure[J]. Circ Res, 2024, 135(2): 372-396.

[3] [3] Shi YJ, Zhang Z, Yin QQ, et al. Cardiac-specific overexpression of miR-122 induces mitochondria-dependent cardiomyocyte apoptosis and promotes heart failure by inhibiting Hand2[J]. J Cell Mol Med, 2021, 25(11): 5326-5334.

[4] [4] Wang HJ, Zhang CW, Li MN, et al. Antimicrobial peptides mediate apoptosis by changing mitochondrial membrane permeability[J]. Int J Mol Sci, 2022, 23(21): 12732.

[5] [5] Green DR. The mitochondrial pathway of apoptosis: part Ⅰ: MOMP and beyond[J]. Cold Spring Harb Perspect Biol, 2022, 14(5): a041038.

[9] [9] Huang DJ, Hua W, Fang Q, et al. Biventricular pacemaker and defibrillator implantation in patients with chronic heart failure in China[J]. ESC Heart Fail, 2021, 8(1): 546-554.

[10] [10] Thandavarayan RA, Chitturi KR, Guha A. Pathophysiology of acute and chronic right heart failure[J]. Cardiol Clin, 2020, 38(2): 149-160.

[11] [11] Han YD, Cao Y, Han XX, et al. Hyperuricemia and gout increased the risk of long-term mortality in patients with heart failure: insights from the National Health and Nutrition Examination Survey[J]. J Transl Med, 2023, 21(1): 463.

[12] [12] Zhuang LF, Jia KN, Chen C, et al. DYRK1B-STAT3 drives cardiac hypertrophy and heart failure by impairing mitochondrial bioenergetics[J]. Circulation, 2022, 145(11): 829-846.

[13] [13] Guan ZJ, Chen J, Wang LH, et al. Nuanxinkang prevents the development of myocardial infarction-induced chronic heart failure by promoting PINK1/Parkin-mediated mitophagy[J]. Phytomedicine, 2023, 108: 154494.

[14] [14] Lin LW, Xu HL, Yao ZY, et al. Jin-Xin-Kang alleviates heart failure by mitigating mitochondrial dysfunction through the calcineurin/dynamin-related protein 1 signaling pathway[J]. J Ethnopharmacol, 2024, 335: 118685.

[15] [15] Zhang W, Yuan SL, Qiang JC, et al. Malvidin mitigates sepsis-induced cardiac injury by modulating the TLR4-iNOS-COX-2 inflammatory pathway and the Bax/Bcl-2/Cyto-C mitochondrial apoptosis pathway in a p38 MAPK-dependent manner[J]. Biomed Environ Sci, 2024, 37(2): 221-227.